Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extended adjuvant letrozole duration study in early breast cancer
NL-OMON23112Recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Apr 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of letrozole in breast cancer (2 arms), sponsored by Leiden University Medical Center. Primary endpoint: Disease-free survival. Started Apr 2007; status: recruiting.
02
Drugs
letrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on NL-OMON23112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON23112.